Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Wave Life Sciences (WVE)

  • Event
  • May 12, 2022, 00:00 UTC
  • 19
  • 1 comments

(42% Neutral) WAVE LIFE SCIENCES LTD. (WVE) Reports Net Loss for 2022-03-31

Comment Full text

None (GMDA)

  • Event
  • May 12, 2022, 00:00 UTC
  • 18
  • 1 comments

(52% Neutral) GAMIDA CELL LTD. (GMDA) Reports Net Loss for 2022-03-31

Comment Full text

Cabaletta Bio Inc (CABA)

  • Event
  • May 12, 2022, 00:00 UTC
  • 18
  • 1 comments

(61% Neutral) CABALETTA BIO, INC. (CABA) Reports Net Loss for 2022-03-31

Comment Full text

Akouos Inc (the company became a subdivision of the company LIlly (LLY)) (AKUS)

  • Event
  • May 12, 2022, 00:00 UTC
  • 18
  • 1 comments

(76% Positive) AKOUOS, INC. (AKUS) Reports 40% Loss Reduction for 2022-03-31

Comment Full text

Evelo Biosciences, Inc. (EVLO)

  • Event
  • May 12, 2022, 00:00 UTC
  • 17
  • 1 comments

(51% Neutral) Evelo Biosciences, Inc. (EVLO) Reports Net Loss for 2022-03-31

Comment Full text

MeiraGTx Holding (MGTX)

  • Event
  • May 12, 2022, 00:00 UTC
  • 27
  • 1 comments

(61% Neutral) MeiraGTx Holdings plc (MGTX) Reports Net Loss for 2022-03-31

Comment Full text

Larimar Therapeutics Inc (LRMR)

  • Event
  • May 12, 2022, 00:00 UTC
  • 29
  • 1 comments

(28% Negative) LARIMAR THERAPEUTICS, INC. (LRMR) Reports 36% Loss Increase for 2022-03-31

Comment Full text

Altimmune Inc (ALT)

  • Event
  • May 12, 2022, 00:00 UTC
  • 30
  • 1 comments

(61% Neutral) ALTIMMUNE, INC. (ALT) Reports Net Loss for 2022-03-31

Comment Full text

Royalty Pharma (RPRX)

  • Event
  • May 11, 2022, 15:32 UTC
  • 27
  • 1 comments

(99% Neutral) Royalty Pharma plc (RPRX) Announces Business Combination

Comment Full text

Genmab (GMAB)

  • Event
  • May 11, 2022, 15:24 UTC
  • 18
  • 1 comments

(30% Negative) Genmab (GMAB) Reports Q2 2022 Financial Results (Form 6-K)

Comment Full text
  • Previous
  • 619
  • 620
  • 621
  • 622
  • 623
  • Next

Search

News categories

  • Technical Exchange News(12517)
  • Event(6229)
  • SEC News(286741)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(162362)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin